SCHEMBL353309

SCHEMBL353309

C1=CCNN=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL8814090 0.97
SCHEMBL17762723 0.75
SCHEMBL12028066 0.71
SCHEMBL18653951 0.69
SCHEMBL9262 0.67
SCHEMBL3542796 0.61
SCHEMBL12028059 0.61
SCHEMBL13192015 0.59
SCHEMBL14693137 0.58
SCHEMBL29410820 0.53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 568 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115322622-B UV curing ink-jet material and preparation method and application thereof 山东布瑞特油墨有限公司 2023-03-31 CN claimed
CN-115322622-A UV curing ink-jet material and preparation method and application thereof 山东布瑞特油墨有限公司 2022-11-11 CN claimed
CN-112645882-B Synthesis method of 1, 6-dihydropyridazine derivative 温州大学新材料与产业技术研究院 2022-06-24 CN claimed
US-11325925-B2 Dihydropyridazine antioxidant sunscreens ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) 2022-05-10 US claimed
US-10975426-B2 Polypeptide tagged nucleotides and use thereof in nucleic acid sequencing by nanopore detection Roche Sequencing Solutions, Inc. (US) 2021-04-13 US claimed
CN-112645882-A Synthesis method of 1, 6-dihydropyridazine derivative 温州大学新材料与产业技术研究院 2021-04-13 CN claimed
US-20200270281-A1 DIHYDROPYRIDAZINE ANTIOXIDANT SUNSCREENS ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA 2020-08-27 US claimed
WO-2019242691-A1 PACLITAXEL-LIPID-POLYSACCHARIDE DUAL-TYPE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF 圣多利康制药责任有限公司 2019-12-26 WO claimed
WO-2019046848-A1 DIHYDROPYRIDAZINE ANTIOXIDANT SUNSCREENS ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) 2019-03-07 WO claimed
CN-103547249-A Dye composition comprising at least four dye precursors including at least one oxidation base and at least one coupler OREAL 2014-01-29 CN claimed
EP-1542692-A1 AMINO-PYRIDINE, -PYRIDINE AND PYRIDAZINE DERIVATIVES FOR USE AS VANILLOID RECEPTOR LIGANDS FOR THE TREATMENT OF PAIN Amgen Inc. (US) 2005-06-22 EP claimed
EP-1463714-A2 VANILLOID RECEPTOR LIGANDS AND THEIR USE IN TREATMENTS Amgen Inc. (US) 2004-10-06 EP claimed
US-20040152690-A1 Vanilloid receptor ligands and their use in treatments AMGEN INC. 2004-08-05 US claimed
US-20040082780-A1 Vanilloid receptor ligands and their use in treatments AMGEN, INC. 2004-04-29 US claimed
WO-2004035549-A1 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS VANILLOID RECEPTOR LIGANDS AMGEN INC. (US) 2004-04-29 WO claimed
US-20040038969-A1 Vanilloid receptor ligands and their use in treatments AMGEN, INC. 2004-02-26 US claimed
WO-2004014871-A1 VANILLOID RECEPTOR LIGANDS AND THEIR USE IN TREATMENTS AMGEN INC. (US) 2004-02-19 WO claimed
WO-2003099284-A1 AMINO-PYRIDINE, -PYRIDINE AND PYRIDAZINE DERIVATIVES FOR USE AS VANILLOID RECEPTOR LIGANDS FOR THE TREATMENT OF PAIN AMGEN INC. (US) 2003-12-04 WO claimed
US-20030195201-A1 Vanilloid receptor ligands and their use in treatments AMGEN INC. 2003-10-16 US claimed
WO-2003049702-A2 VANILLOID RECEPTOR LIGANDS AND THEIR USE IN TREATMENTS AMGEN INC. (US) 2003-06-19 WO claimed